<DOC>
	<DOCNO>NCT00522197</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention use certain drug keep cancer forming . The use ACAPHA , combination six herb , may prevent lung cancer form former smoker bronchial intraepithelial neoplasia . PURPOSE : This randomized phase II trial study side effect well ACAPHA work prevent lung cancer former smoker bronchial intraepithelial neoplasia .</brief_summary>
	<brief_title>ACAPHA Preventing Lung Cancer Former Smokers With Bronchial Intraepithelial Neoplasia</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy safety multi-herbal agent ACAPHA former smoker bronchial intraepithelial neoplasia . - Evaluate whether ACAPHA modulate surrogate endpoint biomarkers aberrant methylation , cell cycle regulation , apoptosis , well phase I II enzyme regulation . - Establish library vivo confocal microendoscopy image correspond histopathology , nuclear morphometry , biomarker information ass potential confocal microendoscopy nonbiopsy method assess effect chemoprevention agent . OUTLINE : Patients stratify accord gender . Patients randomize 1 2 arm . - Arm I : Patients receive oral multi-herbal agent ACAPHA twice daily 6 month . Patients achieve partial response receive additional 6 month ACAPHA . - Arm II : Patients receive oral placebo twice daily 6 month . Patients achieve partial response receive additional 6 month placebo . Patients progressive disease receive ACAPHA twice daily 6 month . Patients undergo sputum cytology , oral bronchial brushing , bronchoalveolar lavage , bronchial tissue biopsy baseline 6 12 month . Samples analyze histopathological morphometric cell change ; MIB-1 bcl-2 , TUNEL immunostaining ; methylation biomarkers ; gene expression analysis RNA . After completion study therapy , patient follow 1 6 month .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : One area bronchial intraepithelial neoplasia ( IEN ) ( metaplasia/dysplasia ) nuclear morphometry index &gt; 1.36 surface diameter &gt; 1.2 mm autofluorescence bronchoscopy Atypical sputum cell determine computerassisted image analysis Former smoker ( i.e. , stop smoke least 1 year ago ) smoke least 30 packyears ( i.e. , 1 pack/day 30 year ) Exhaled carbon monoxide level &lt; 5 ppm No invasive cancer bronchoscopy abnormal spiral chest CT scan suspicious lung cancer PATIENT CHARACTERISTICS : ECOG performance status 0 1 Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Normal renal function test ( BUN , creatinine , urinalysis ) Normal liver function test ( AST , ALT , bilirubin , alkaline phosphatase ) No chronic active hepatitis liver cirrhosis No acute bronchitis pneumonia within past month No know reaction xylocaine No medical condition , opinion investigator , could jeopardize patient 's safety participation study , include follow : Acute chronic respiratory failure Unstable angina Uncontrolled congestive heart failure Bleeding disorder PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
	<keyword>squamous lung dysplasia</keyword>
</DOC>